Download PDF
Thromb Haemost 1999; 81(04): 667
DOI: 10.1055/s-0037-1614549
Letters to the Editor
Schattauer GmbH

Thrombosis and Disseminated Intravascular Coagulation following Treatment with the Prothrombin Complex Concentrate, DEFIX

P. H. Roddie
1   From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK
,
C. Stirling
1   From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK
,
E. E. Mayne
1   From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK
,
C. A. Ludlam
1   From the Dept. of Haematology, Royal Infirmary of Edinburgh, Edinburgh, UK
› Author Affiliations
Further Information

Publication History

Received 06 November 1998

Accepted 10 December 1998

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 BCSH guidelines on oral anticoagulation: third edition. Br J Haematol. 1998; 101: 374-87.
    PubMedGoogle Scholar
  • 2 Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR. Preston EF.Emergency oral anticoagulant reversal: the relative efficacy of infusions offresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477-80.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Lusher JM. Prediction and management of adverse events associated withthe use of factor IX complex concentrates. Semin Hematol 1993; 30: 36-40.
    PubMedGoogle Scholar
  • 4 Prowse CV, Cash JD. The use of factor IX concentrates in man: a 9-year experience of Scottish concentrates in the South-East of Scotland. Br J Haematol 1981; 47: 91-104.
    CrossrefPubMedGoogle Scholar
  • 5 McNeill SA, Ewing JC, Wallace WA, Stewart LH. Venous infarction of atesticle following factor IX concentrate (DEFIX) [letter]. Br J Haematol 1998; 101-210.
    PubMedGoogle Scholar